Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 17 - Caught on Camera

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD). The study met two co-primary objectives, associated with immunogenicity responses. Pfizer shares traded in a range of $48.55 to…

Benzinga

More than a half billion doses of COVID vaccine made in Baltimore dumped, congressional panel finds

BALTIMORE — The tally of wasted COVID-19 vaccine continues to climb at the troubled Emergent BioSolutions plant in East Baltimore and now exceeds a half billion doses, according to findings a congressional panel released Thursday on the manufacturer once central to the U.S. coronavirus pandemic response.

Tribune News Service

Zed admits 'deep sense of dread' before election loss

In his first media interview since losing his Senate seat, Zed Seselja said he believed voters had made up their minds about the Morrison government before the election.

The Canberra Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Climate change puts Lyme disease in focus for France's Valneva after COVID blow

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

Reuters

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

AstraZeneca raises sales guidance on demand for Covid treatment

The Anglo-Swedish pharmaceutical giant said it expects the Evusheld Covid-19 injection to help drive sales of at least 20% for the year.

The Independent UK

AstraZeneca claims to have saved six million lives with COVID vaccine

Group profit in the first half of the year spiked by 48% as Michel Demaré lined up for chair

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Covid vaccine figures lay bare global inequality as global target missed

Only one in seven people in low-income countries are fully vaccinated with poorest pushed to the ‘back of the queue’

The Guardian - UK

This Is What Whales Are Betting On AstraZeneca

Someone with a lot of money to spend has taken a bearish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Jabs 'saved half a million people'

A research team from Mahidol University has estimated that the government's Covid-19 vaccination campaign over the past two years prevented nearly 490,000 deaths.

Bangkok Post

Cancer drug found to regenerate a damaged spine

AZD1390 is under investigation by AstraZeneca, who helped develop a Covid-19 vaccine that has seen more than two billion doses released worldwide

Wales Online

Bhutan-China ties won’t harm India’s interests: Bhutan Foreign Minister

After over two years of COVID-19-induced lockdown, Bhutan will open its doors for tourists on September 23 with a new expensive policy for international tourists and Indians as well. Bhutan Foreign Minister Tandi Dorji says the lessons of COVID-19 include better ties with neighbours, including China.

The Hindu

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

360info

Patent waiver is no silver bullet, even during COVID-19

Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.

The Independent UK

1.1 billion Covid vaccine doses wasted globally, estimates suggest

‘A lot of Covid-19 vaccine wastage has been driven by the deeply unequal global response to this pandemic,’ says global health campaigner

The Conversation

COVID vaccines and pregnancy: a review of the evidence shows they are safe

COVID vaccines have been contentious ever since they were developed in response to the coronavirus pandemic, though the evidence is that they are safe and effective. One of the concerns has been whether the vaccines were safe for pregnant women. A recent review looked at the evidence available from North…

ABC News

Experts say there are a number of factors to weigh up about getting a fourth dose of a COVID-19

As millions more people become eligible for a fourth COVID vaccine dose, you might be asking whether you should book in for it or wait for Omicron-specific vaccines still being developed.

Get all your
news in one place.

100's of premium titles.
One news app.

ABC News

Thinking of mixing and matching COVID-19 vaccine booster shots? There doesn't seem to be much point

Most people will have the Moderna or the Pfizer vaccine for their fourth dose. But the Doherty Institute's head of vaccine and immunisation research says there's practically no difference between them.

Bangkok Post

Ministry signs contract to buy long-acting antibody drug

The Ministry of Public Health on Wednesday signed a procurement agreement with AstraZeneca for 257,500 doses of the long-acting antibody drug Evusheld, which boosts Covid-19 immunity in patients with low immunity levels.

The Guardian - AU

Canada to throw out 13.6m AstraZeneca Covid vaccine doses amid lack of demand

Government pledged to donate millions of doses to other countries but they were ‘not accepted’ despite fresh rise in coronavirus cases around the world

Wales Online

Canada throwing away 13.6m doses of AstraZeneca Covid vaccine that nobody wants

Oxford AstraZeneca vaccine fell out of favour amid concerns about rare but potentially fatal blood clots

Benzinga

Benzinga Before The Bell: Record Inflows In 'Short Bitcoin' Funds, Elon Musk's Trillionaire Possibility, Gmail's Political Bias And Other Top Financial Stories Tuesday, July 5

Reuters

Benzinga

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine

Oxford Biomedica plc (OTC:OXBDF) signed a new three-year agreement to potentially make AstraZeneca Plc's (NASDAQ:AZN) COVID-19 vaccine beyond 2022. The new agreement represents an expansion of the original master supply and development agreement announced between the two companies in September 2020. The manufacture of COVID-19 vaccines at Oxford Biomedica's Oxbox facility, as part of the…

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.